Monthly Archives - January 2018

30Jan

Corbus Pharmaceuticals Announces Agreement with FDA on Phase 2b Cystic Fibrosis Study Design with Pulmonary Exacerbations as Sole Primary Endpoint

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration ("FDA") regarding the design of its next study of lenabasum (formerly known as anabasum), a novel, oral, pro-resolving drug, in the treatment of cystic fibrosis ("CF"). Read more >>
Portfolio News
Read more...
28Jan

Snow Skiing is like Starting a Business? Roger that!

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. You've heard it before. Starting a business is a lot like skiing: you've got to be prepared for a fall. In episode eight, guest Roger Kahlon, a businessman and avid skier, speaks on the topic from first hand experience.  Tune in >>
Blog, Member News, ,
Read more...
25Jan

Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life Sciences Center (MLSC) today celebrated Myomo’s repayment of a $750,000 accelerator loan provided by the MLSC in 2011. Myomo completed repayment of the loan, which totaled $1,350,618 with interest, on December 13, 2017. Myomo Chairman and CEO Paul R. Gudonis presented a ceremonial check to Travis McCready, President and CEO of MLSC, during a ceremony at Myomo’s headquarters in the Cambridge...
Portfolio News
Read more...
24Jan

‘Bone Glue’ Experiments on the ISS Test Possible Treatment for Osteoporosis

“If we can show that our material stimulates the production of new bone in the space environment, that will have a translational value back on Earth, that it could be used to someday treat patients with osteoporosis,” said Brian Hess, founder and CEO of Launchpad Medical, which created the glue. “But it could also be a material to help treat astronauts from the effects of deep space travel. That’s obviously a secondary reason of why we are studying this in...
Portfolio News
Read more...